| Balance Sheets | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 2,685,600 | 3,272,800 | 3,140,600 | 3,676,400 |
| Short-term investments (note 5) | 1,156,400 | 789,400 | 757,900 | 769,700 |
| Accounts receivable, net of allowances of 12.6 and 11.6, respectively | 693,300 | 697,000 | 669,200 | 716,000 |
| Other receivables | 199,500 | 205,600 | 82,700 | 95,500 |
| Inventories (note 2) | 1,140,900 | 1,141,700 | 1,113,900 | 1,104,200 |
| Prepaid expenses | 125,200 | 110,000 | 111,300 | 114,900 |
| Other current assets | 323,400 | 314,400 | 304,500 | 231,000 |
| Current assets of discontinued operations (note 4) | 34,600 | 46,300 | 32,600 | 20,000 |
| Total current assets | 6,358,900 | 6,577,200 | 6,212,700 | 6,727,700 |
| Long-term investments (note 5) | 274,700 | 298,500 | 277,900 | 319,600 |
| Property, plant, and equipment, net | 1,743,300 | 1,726,600 | 1,698,300 | 1,675,700 |
| Operating lease right-of-use assets | 96,500 | 99,000 | 96,900 | 104,400 |
| Goodwill | 1,768,500 | 1,776,700 | 1,778,700 | 1,605,300 |
| Other intangible assets, net | 1,130,800 | 1,172,800 | 1,174,900 | 956,100 |
| Deferred income taxes | 1,099,900 | 1,082,100 | 1,027,800 | 888,400 |
| Other assets (note 2) | 784,800 | 743,000 | 742,700 | 683,500 |
| Non-current assets of discontinued operations (note 4) | 14,800 | 12,800 | 12,400 | 10,500 |
| Total assets | 13,272,200 | 13,488,700 | 13,022,300 | 12,971,200 |
| Accounts payable | 165,000 | 162,100 | 172,400 | 172,800 |
| Accrued and other liabilities (note 2) | 1,393,900 | 1,214,400 | 1,196,400 | 1,745,300 |
| Operating lease liabilities | 26,800 | 25,900 | 23,700 | 24,200 |
| Current liabilities of discontinued operations (note 4) | 2,300 | 2,300 | 2,300 | 1,800 |
| Total current liabilities | 1,588,000 | 1,404,700 | 1,394,800 | 1,944,100 |
| Long-term debt | 598,200 | 598,000 | 597,800 | 597,500 |
| Taxes payable | - | - | - | 1,100 |
| Operating lease liabilities | 75,300 | 78,700 | 77,900 | 85,000 |
| Uncertain tax positions | 442,900 | 421,600 | 402,600 | 345,600 |
| Litigation settlement accrual | - | - | - | 63,900 |
| Other liabilities | 362,600 | 379,200 | 357,600 | 322,600 |
| Non-current liabilities of discontinued operations (note 4) | 200 | - | - | 0 |
| Total liabilities | 3,067,200 | 2,882,200 | 2,830,700 | 3,359,800 |
| Total edwards lifesciences corporation stockholders' equity | 10,205,000 | 10,545,300 | 10,128,700 | 9,545,600 |
| Noncontrolling interest | 0 | 61,200 | 62,900 | 65,800 |
| Total stockholders' equity | 10,205,000 | 10,606,500 | 10,191,600 | 9,611,400 |
| Total liabilities and equity | 13,272,200 | 13,488,700 | 13,022,300 | 12,971,200 |
Edwards Lifesciences Corp (EW)
Edwards Lifesciences Corp (EW)